Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

MDGL Madrigal Pharmaceuticals Inc

314,2925

1,18 (0,38%)

Zuletzt aktualisiert: 18:18:14

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/21/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Carole Huntsman

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Madrigal Pharmaceuticals Charts.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Madrigal Pharmaceuticals Charts.

News Madrigal Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 22 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
Mittwoch 6 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 1 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Madrigal Pharmaceuticals Inc News-Artikel

Invesco QQQ Trust Series 1

Financial Select Sector

Deutsche Lufthansa

JP Morgan Chase

Health Care Select Sector

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen